TD Cowen Maintains Buy on CME Group, Raises Price Target to $300

Benzinga Newsdesk www.benzinga.com Positive 76.5%

Neg 0% Neu 0% Pos 76.5%

TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.

Comments

No comments yet. Be the first!